T2D and CV Risk Reduction: Future Management

(8:3)

Managing T2D and CVD in Older Adults

(1:8)

ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD

(35:39)

GLP-1 Agonist Therapy in a Patient With T2D and CVD

(6:15)

Using GLP-1 Agonists in Patients With T2D and CVD

(4:59)

Team-based care for patients with T2D and kidney disease | Katherine R Tuttle \u0026 Jay H Shubrook

(8:39)

Unleashing the Truth: Treating T2D and Its Associated Co-Morbidities

(1:1econd)

Ask the Experts: Taking Care of Diabetes and Heart Health When Your Routine is Interrupted

(59:23)

T2D and CV Risk Reduction: Treating the Whole Patient

(8:10)

Diabetes Won’t Wait: Talk To A Doctor About T2D and Preventative Care

(16)

Clinical Consult: Hyperkalemia in Patients With T2D and CKD

(30:58)

Impressions of a Patient With T2D and CVD

(3:49)

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

(5:8)

Novel Strategies for T2D and Comorbid Conditions

(5:39)

The management of chronic kidney disease (CKD) in patients with T2D

(38:26)

Treating T2D and prediabetes in youth, use of CGMs in hospital settings, the art of Diabetes Care...

(58:6)

Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Trea...

(22:30)

T2D and Lifestyle Nutrition Advocacy

(22:53)

Approaching Integrated Care in T2D and its Related Conditions

(31)

Evidence-Based Treatment: T2D and Heart Failure

(35)